Umbilical cord mesenchymal stem cell therapy (Kangstem Biotech)

N/A

Report date: 2024/11/26 20:00:06

Base Information

Drug NameUmbilical cord mesenchymal stem cell therapy (Kangstem Biotech)
Drug Alias NameFURESTEM-CDFURESTEM-ADhUCB-MSCsFURESTEM
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPsoriasisDermatitis, AtopicCrohn Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKangstem Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKangstem Biotech Co Ltd
Inactive CompaniesMedipost Co Ltd
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsPsoriasisDermatitis, AtopicCrohn Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A